• 54,667+ CME Conference Registrations Sold
  • 164,002+ Medical Conferences
  • 284 Specialties
  • 11,702 Organizers
  • 159,414 Speakers
  • 159 Countries
  • 4,842 Cities
Home  >  Speakers  >  Jack A. Ragheb
Jack A. Ragheb

Jack A. Ragheb

    MD, PhD
Scientific Founder, Senior Medical Fellow | Bethesda, Maryland    United States of America
Genetics, Immunology And Microbiology
Immunology, Biotechnology,...More
Spoken at 4 events

Biography :

Dr. Ragheb has been with Eli Lilly & Co. for about 3 years. He is based in Indianapolis where he serves as the Senior Medical Fellow for Immunology in Global Patient Safety and Co-Chair of the Immunogenicity/Immunosafety Working Group.

He received his MD and Ph.D. degrees from the Johns Hopkins University and is a Diplomate of the American Board of Allergy & Immunology. Formerly, he was a Senior Clinical Investigator at NIH where he conducted clinical and basic research on immune tolerance and a Chief Medical Research Officer in the Office of Biological Products at the FDA where his research group established the BLT humanized mouse model there in an effort to predict the immunogenicity of biotherapeutics. He has published in the areas of immunogenicity, immune tolerance, CD28 and CD40L regulation, retrovirology and gene therapy.

**********************
***** ********
 
For speaker's contact information - Contact us

Specialties

Genetics, Immunology and Microbiology

Interested Topics

Immunology, Biotechnology, Epidemiology, Infectious Diseases, Molecular Biology, Assay Development, Drug Development, Clinical Trials

State Licenses

This section has yet to be updated by the speaker.

Board Certifications

This section has yet to be updated by the speaker.

Professional Association

This section has yet to be updated by the speaker.

Languages

English

Conference Session Materials

The conference session material has yet to be added by the speaker.
X

Send Message

Convert
Onsite to Virtual Conference

Market your online event to Million plus Healthcare professionals.